Health
World’s First Phase III Clinical Trial of COVID-19 Inactivated Vaccine Begins in UAE – Up News Info
Article content continued It follows successful phase I and II trials by Sinopharm in China, resulting in 100% of volunteers generating antibodies. G42 Healthcare CEO Ashish Koshy said: “We are enormously proud to partner with Sinopharm CNBG in this groundbre…
It follows successful phase I and II trials by Sinopharm in China, resulting in 100% of volunteers generating antibodies.
G42 Healthcare CEO Ashish Koshy said: We are enormously proud to partner with Sinopharm CNBG in this groundbreaking phase III clinical trial. Using our AI solutions, super-computer, advanced diagnostics solutions for COVID-19, and G42 Healthcare will be responsible for running clinical operations for these trials.
Jingjin Zhu, President, Biological products, Sinopharm CNBG …
-
General11 hours agoAllegations against ex-Attorney-General Mark Dreyfus removed from Linda Reynolds action against Commonwealth
-
Noosa News10 hours agoToombul Shopping Centre site thrown lifeline after Mirvac announces sale with ‘priority’ to build new retail centre
-
General21 hours agoLiberal politicians on Qantas plane that made urgent turnaround to Adelaide
-
Noosa News23 hours agoTeen to be sentenced over stabbing of grandmother Vyleen White; Victoria follows Queensland with ‘adult time for violent crime’ laws